Cargando…
ELK4 Promotes Colorectal Cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3‐Dependent Manner
Although the MAPK/MEK/ERK pathway is prevalently activated in colorectal cancer (CRC), MEK/ERK inhibitors show limited efficiency in clinic. As a downstream target of MAPK, ELK4 is thought to work primarily by forming a complex with SRF. Whether ELK4 can serve as a potential therapeutic target is un...
Autores principales: | Zhu, Zhehui, Guo, Yuegui, Liu, Yun, Ding, Rui, Huang, Zhenyu, Yu, Wei, Cui, Long, Du, Peng, Goel, Ajay, Liu, Chen‐Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646254/ https://www.ncbi.nlm.nih.gov/pubmed/37786278 http://dx.doi.org/10.1002/advs.202303378 |
Ejemplares similares
-
Mechanical strain promotes skin fibrosis through LRG-1 induction mediated by ELK1 and ERK signalling
por: Gao, Ya, et al.
Publicado: (2019) -
CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis
por: Guo, Yuegui, et al.
Publicado: (2022) -
Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activation
por: Yang, Jimin, et al.
Publicado: (2023) -
Expression of thioredoxin-1 and hypoxia inducible factor-1α in cerebral arteriovenous malformations: Possible role of redox regulatory factor in neoangiogenic property
por: Takagi, Yasushi, et al.
Publicado: (2011) -
LRG1: an emerging player in disease pathogenesis
por: Camilli, Carlotta, et al.
Publicado: (2022)